Morgan Stanley »

Sionna Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $764k 44k 17.35

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Perceptive Advisors
Vanguard Group
Jennison Associates
Deerfield Management Company
Standard Life Aberdeen
BlackRock
Soleus Capital Management
Baker Bros. Advisors

View all funds holding Sionna Therapeutics